U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07317180) titled 'Meta Glasses for Low Vision' on Dec. 19, 2025.
Brief Summary: Visual impairment, particularly from glaucoma and retinal dystrophies, significantly hinders mobility and increases the risk of falls, leading to decreased independence and mental health challenges. Current low-vision assistive technologies primarily focus on near-task magnification for reading, leaving a critical gap in tools designed to assist with real-world navigation and peripheral vision loss. To address this, the proposed research evaluates Meta AI glasses, which offer real-time scene narration and object recognition, integrated with the Be My Eyes network. The stud...